
1. j biomed res. 2017 jul 13;31(4):321-332. doi: 10.7555/jbr.31.20160025.

safety, immunogenicity, cross-species protection plasmid dna encoding
plasmodium falciparum sera5 polypeptide, microbial epitopes chemokine genes
in mice olive baboons.

onkoba n(1)(2), mumo r(1)(3), ochanda h(2), omwandho c(3)(4), ozwara h(1), g 
egwang t(5).

author information: 
(1)department tropical & infectious diseases, institute primate research,
nairobi p. o. box 24481-00502, kenya.
(2)school biological sciences, university nairobi, nairobi p. o. box
30197-00100, kenya.
(3)department biochemistry, school medicine, university nairobi, nairobi
p. o. box 30197-00100, kenya.
(4)kirinyaga university college, kerugoya p. o. box 143-10300, kenya.
(5)med-biotech laboratories, kampala p. o. box 9364, uganda.

incorporation biomolecular epitopes malarial antigens explored in
the development strain-transcending malarial vaccines. present study
sought determine safety, immunogenicity cross-species efficacy
ofplasmodium falciparum serine repeat antigen 5 polypeptide co-expressed with
epitopes bacille-calmette guerin (bcg), tetanus toxoid (tt) chemokine
gene. olive baboons balb/c mice randomly assigned vaccine and
control groups. vaccine group animals primed boosted twice with
pires plasmids encoding sera5+ bcg+ tt alone, either ccl5 ccl20
and control group pires plasmid vector backbone. mice baboons were
challenged withp. berghei anka p. knowlesi h strain parasites, respectively. 
safety determined observing injection sites reactogenicities,
hematology clinical chemistry. parasitaemia survivorship profiles were
used determine cross-species efficacy, cell phenotypes, th1-, th2-type, 
t-regulatory immune responses antibody responses assessed determine
vaccine immunogenicity. psebcgtt plasmid dna vaccines safe induced
th1-, th2-type, t-regulatory responses vaccinated animals showed enhanced
cd4+ (p<0.01), cd 8+ cells (p<0.001) activation igg anti-se36 antibodies
responses (p<0.001) week 4 8 post vaccination compared control
group. vaccinated mice 31.45-68.69% cumulative parasite load reduction 
60% suppression baboons (p<0.05) enhanced survivorship (p<0.001) no
clinical signs malaria compared control group. results showed 
the vaccines safe, immunogenic conferred partial cross-species
protection.

doi: 10.7555/jbr.31.20160025 
pmcid: pmc5548993
pmid: 28808204 

